"Ionizable lipid nanoparticles advance translation of mRNA-based vaccines & therapy” - Gairdner Week

Prof. Bowen Li, an Early Career Investigator Awardee, presented "Delivering a hopeful message: Ionizable lipid nanoparticles advance the translation of mRNA-based vaccines and therapy” at the 2022 Gairdner Science Week Laureate Lectures.

Dr. Li received Ph.D. in Bioengineering from the University of Washing-Seattle (2019), and then completed his postdoc training under the supervision of Profs. Bob Langer and Daniel Anderson at Massachusetts Institute of Technology (2022). Since starting his independent lab at the University of Toronto in Feb. 2022, he has received the J. P. Bickell Foundation Medical Research Award, the UofT LDFP New Initiative and Innovation Award, the Connaught New Researcher Award and was nominated for the Tier 2 Canada Research Chair in RNA Vaccines and Therapeutics. His lab leverages new technology platforms such as machine learning and organ-on-a-chip to accelerate the development of delivery vehicles for engineered, bespoke nucleic acids, including mRNA and CRISPR-Cas9, with an overall objective to advance transformative research and early-stage translation of RNA medicines for vaccination, immunotherapy, gene therapy, and regenerative medicine.